Tourette Syndrome Treatment Market Size & Share Report, 2032

Tourette Syndrome Treatment Market – By Treatment Type (Medication, Behavioural Therapy, Deep Brain Stimulation), Disease Type (Motor Tics, Vocal Tics), Age Group (Pediatric, Adult), End-use (Hospitals, Specialty Clinics), Global Forecast 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Growing prevalence of neurological disorders

3.2.1.2&nbsp;&nbsp;&nbsp; Advancements in drug development

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of advanced therapies

3.2.2.2&nbsp;&nbsp;&nbsp; Side effects and adverse reactions

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Future market trends

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Treatment Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Medication

5.2.1&nbsp;&nbsp;&nbsp; Alpha-adrenergic agonists

5.2.2&nbsp;&nbsp;&nbsp; Antipsychotics

5.2.3&nbsp;&nbsp;&nbsp; Stimulants

5.2.4&nbsp;&nbsp;&nbsp; Botulinum toxin injection

5.2.5&nbsp;&nbsp;&nbsp; Other medication types

5.3&nbsp;&nbsp;&nbsp; Behavioral therapy

5.3.1&nbsp;&nbsp;&nbsp; Comprehensive Behavioral Intervention for Tics (CBIT)

5.3.2&nbsp;&nbsp;&nbsp; Habit reversal training

5.4&nbsp;&nbsp;&nbsp; Deep brain stimulation (DBS)

5.5&nbsp;&nbsp;&nbsp; Other treatment types

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Disease Type, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Motor tics

6.3&nbsp;&nbsp;&nbsp; Vocal tics

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Age Group, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Pediatric

7.3&nbsp;&nbsp;&nbsp; Adult

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-Use, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Hospitals

8.3&nbsp;&nbsp;&nbsp; Specialty clinics

8.4&nbsp;&nbsp;&nbsp; Homecare settings

8.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Netherlands

9.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Service Provider

10.1.1&nbsp;&nbsp;&nbsp; Boston Children&#39;s Hospital

10.1.2&nbsp;&nbsp;&nbsp; Mayo Clinic

10.1.3&nbsp;&nbsp;&nbsp; Stony Brook Medicine

10.1.4&nbsp;&nbsp;&nbsp; Massachusetts General Hospital

10.1.5&nbsp;&nbsp;&nbsp; UPMC Children&#39;s Hospital of Pittsburgh

10.2&nbsp;&nbsp;&nbsp; Medication Manufacturer

10.2.1&nbsp;&nbsp;&nbsp; AstraZeneca PLC

10.2.2&nbsp;&nbsp;&nbsp; Bausch Health Companies Inc.

10.2.3&nbsp;&nbsp;&nbsp; Catalyst Pharmaceuticals, Inc.

10.2.4&nbsp;&nbsp;&nbsp; Eli Lilly and Company

10.2.5&nbsp;&nbsp;&nbsp; Emalex Biosciences, Inc.

10.2.6&nbsp;&nbsp;&nbsp; Novartis AG

10.2.7&nbsp;&nbsp;&nbsp; Otsuka Pharmaceutical Co., Ltd.

10.2.8&nbsp;&nbsp;&nbsp; Sun Pharmaceutical Industries Limited

10.2.9&nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries Limited

&nbsp;&nbsp;&nbsp;

Tourette Syndrome Treatment Market

Get a free sample of this report